Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis

BACKGROUND: The association between performance status (PS) and the prognosis of metastatic renal cell carcinoma (mRCC) patients receiving tyrosine kinase inhibitors (TKIs) remains controversial. The aim of this study is to evaluate the prognostic value of PS in mRCC patients treated with TKIs. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yawei, Zhang, Yuanyuan, Wang, Xianhao, Kang, Jiaqi, Liu, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385458/
https://www.ncbi.nlm.nih.gov/pubmed/30795756
http://dx.doi.org/10.1186/s12885-019-5375-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385458/
https://www.ncbi.nlm.nih.gov/pubmed/30795756
http://dx.doi.org/10.1186/s12885-019-5375-0

Ejemplares similares